Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
167.64
+5.56 (3.43%)
Nov 21, 2025, 4:00 PM EST - Market closed
CRL Market Cap
CRL has a market cap or net worth of $8.25 billion as of November 24, 2025. Its market cap has decreased by -24.68% in one year.
Market Cap
8.25B
Enterprise Value
10.67B
1-Year Change
-24.68%
Ranking
Category
Stock Price
$167.64
Market Cap Chart
Since June 23, 2000, CRL's market cap has increased from $226.30M to $8.25B, an increase of 3,545.82%. That is a compound annual growth rate of 15.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 8.25B | -12.60% |
| Dec 31, 2024 | 9.44B | -22.16% |
| Dec 29, 2023 | 12.13B | 9.38% |
| Dec 30, 2022 | 11.09B | -41.69% |
| Dec 31, 2021 | 19.01B | 52.98% |
| Dec 31, 2020 | 12.43B | 66.59% |
| Dec 31, 2019 | 7.46B | 37.05% |
| Dec 31, 2018 | 5.44B | 5.01% |
| Dec 29, 2017 | 5.18B | 43.75% |
| Dec 30, 2016 | 3.61B | -3.79% |
| Dec 31, 2015 | 3.75B | 25.52% |
| Dec 31, 2014 | 2.99B | 17.00% |
| Dec 31, 2013 | 2.55B | 40.28% |
| Dec 31, 2012 | 1.82B | 34.64% |
| Dec 30, 2011 | 1.35B | -34.13% |
| Dec 31, 2010 | 2.05B | -7.60% |
| Dec 31, 2009 | 2.22B | 25.20% |
| Dec 31, 2008 | 1.77B | -60.32% |
| Dec 31, 2007 | 4.47B | 54.46% |
| Dec 29, 2006 | 2.89B | -5.57% |
| Dec 30, 2005 | 3.06B | 2.77% |
| Dec 31, 2004 | 2.98B | 89.75% |
| Dec 31, 2003 | 1.57B | -9.52% |
| Dec 31, 2002 | 1.74B | 17.55% |
| Dec 31, 2001 | 1.48B | 50.25% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |